Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features (vol 11, 627325, 2021)

被引：1

作者：

Li, Mingxiao ^{[1
]}

Ren, Xiaohui ^{[1
]}

Dong, Gehong ^{[2
]}

Wang, Jincheng ^{[3
]}

Jiang, Haihui ^{[1
]}

Yang, Chuanwei ^{[1
]}

Zhao, Xuzhe ^{[1
]}

Zhu, Qinghui ^{[1
]}

Cui, Yong ^{[1
]}

Yu, Kefu ^{[4
]}

Lin, Song ^{[1
,5
,6
]}

机构：

[1] Capital Med Univ, Beijing Tiantan Hosp, Natl Clin Res Ctr Neurol Dis, Dept Neurosurg, Beijing, Peoples R China

[2] Capital Med Univ, Beijing Tiantan Hosp, Dept Pathol, Beijing, Peoples R China

[3] Peking Univ Canc Hosp, Dept Radiol, Beijing, Peoples R China

[4] Capital Med Univ, Beijing Tiantan Hosp, Dept Pharm, Beijing, Peoples R China

[5] Inst Brain Disorders, Ctr Brain Tumor, Beijing Key Lab Brain Tumor, Beijing, Peoples R China

[6] Capital Med Univ, Beijing Neurosurg Inst, Dept Neurosurg, Beijing, Peoples R China

来源：

FRONTIERS IN ONCOLOGY | 2021年 / 11卷

关键词：

pseudoprogression; MGMT promoter methylation; subventricular zone; IDH wild-type; glioblastoma; random forest; nomogram;

D O I：

10.3389/fonc.2021.700599

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：1